Mar 28, 2017 Last Updated 3:31 PM, Mar 23, 2017

Multiple sclerosis: Generic glatiramer acetate — a step toward cheaper MS drugs?

Published in News
Read 1046 times
Rate this item
(0 votes)

A randomized, double-blind, phase III trial of generic glatiramer acetate has shown equivalent efficacy and safety compared with the approved formulation, Copaxone. The impact of approval of generic glatiramer acetate, however, will mainly depend on the pricing of the drug. 

Per Soelberg Sørensen
Nature Reviews Neurology; 04 December 2015

Full Text

Last modified on Thursday, 17 December 2015 08:06
Login to post comments

Registered area

Thanks to the support of
merck serono biogen sanofi

JNIInternational Brain Research Organization
Bringing Neuroscience to the World
JNIJournal of Neuroimmunology
Studies on all branches of neurosciences covering both research and clinical problems of neuroscientific interest.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie Policy